These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3044474)

  • 1. Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial.
    Davies UM; Palmer RG; Denman AM
    Br J Rheumatol; 1988 Aug; 27(4):300-2. PubMed ID: 3044474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide in severe orogenital ulceration.
    Jenkins JS; Powell RJ; Allen BR; Littlewood SM; Maurice PD; Smith NJ
    Lancet; 1984 Dec; 2(8417-8418):1424-6. PubMed ID: 6151044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pimecrolimus versus placebo in genital aphthous ulcers of Behcet's disease: a randomized double-blind controlled trial.
    Chams-Davatchi C; Barikbin B; Shahram F; Nadji A; Moghaddassi M; Yousefi M; Davatchi F
    Int J Rheum Dis; 2010 Aug; 13(3):253-8. PubMed ID: 20704623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behçet's disease.
    Firestein GS; Gruber HE; Weisman MH; Zvaifler NJ; Barber J; O'Duffy JD
    Am J Med; 1985 Jul; 79(1):65-72. PubMed ID: 4014306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.
    Gardner-Medwin JM; Smith NJ; Powell RJ
    Ann Rheum Dis; 1994 Dec; 53(12):828-32. PubMed ID: 7864692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical observations on Behçet's disease in Tianjin, China.
    Geng L; Ohno S; Wang YH; Higuchi M
    Jpn J Ophthalmol; 1985; 29(3):310-4. PubMed ID: 4079128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind trial of depot corticosteroids in Behçet's syndrome.
    Mat C; Yurdakul S; Uysal S; Gogus F; Ozyazgan Y; Uysal O; Fresko I; Yazici H
    Rheumatology (Oxford); 2006 Mar; 45(3):348-52. PubMed ID: 16263779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
    Hatemi G; Melikoglu M; Tunc R; Korkmaz C; Turgut Ozturk B; Mat C; Merkel PA; Calamia KT; Liu Z; Pineda L; Stevens RM; Yazici H; Yazici Y
    N Engl J Med; 2015 Apr; 372(16):1510-8. PubMed ID: 25875256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study.
    Grayson PC; Yazici Y; Merideth M; Sen HN; Davis M; Novakovich E; Joyal E; Goldbach-Mansky R; Sibley CH
    Arthritis Res Ther; 2017 Mar; 19(1):69. PubMed ID: 28335798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of aciclovir on ulcer healing, lesional, genital and plasma HIV-1 RNA among patients with genital ulcer disease in Malawi.
    Phiri S; Hoffman IF; Weiss HA; Martinson F; Nyirenda N; Kamwendo D; Fiscus SA; Chen CY; Miller WC; van der Hoeven L; Chilongozi D; Cohen MS; Mayaud P
    Sex Transm Infect; 2010 Oct; 86(5):345-52. PubMed ID: 20444742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Behçet's disease.
    Köse O; Dinç A; Simşek I
    Dermatology; 2009; 218(2):140-5. PubMed ID: 19060462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease.
    Bacanli A; Yerebakan Dicle O; Parmaksizoglu B; Yilmaz E; Alpsoy E
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):931-5. PubMed ID: 16922940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab treatment for severe orogenital ulceration in Behçet's disease.
    Connolly M; Armstrong JS; Buckley DA
    Br J Dermatol; 2005 Nov; 153(5):1073-5. PubMed ID: 16225632
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab.
    Robertson LP; Hickling P
    Rheumatology (Oxford); 2001 Apr; 40(4):473-4. PubMed ID: 11312390
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome.
    Keogan MT
    Clin Exp Immunol; 2009 Apr; 156(1):1-11. PubMed ID: 19210521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial.
    Hamuryudan V; Mat C; Saip S; Ozyazgan Y; Siva A; Yurdakul S; Zwingenberger K; Yazici H
    Ann Intern Med; 1998 Mar; 128(6):443-50. PubMed ID: 9499327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behçet's syndrome with arthritis.
    Mason RM; Barnes CG
    Ann Rheum Dis; 1969 Mar; 28(2):95-103. PubMed ID: 5777255
    [No Abstract]   [Full Text] [Related]  

  • 18. Dapsone use with oral-genital ulcers.
    Handfield-Jones S; Allen BR; Littlewood SM
    Br J Dermatol; 1985 Oct; 113(4):501. PubMed ID: 4063186
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease: a randomized, placebo-controlled, double-blind study.
    Alpsoy E; Er H; Durusoy C; Yilmaz E
    Arch Dermatol; 1999 May; 135(5):529-32. PubMed ID: 10328192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation and treatment of orogenital ulceration; studies on a possible mode of action of thalidomide.
    Powell RJ; Allen BR; Jenkins JS; Steele L; Hunneyball I; Maurice PD; Littlewood SM
    Br J Dermatol; 1985 Jul; 113 Suppl 28():141-4. PubMed ID: 4040386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.